Earnings Summary

Cg Oncology Inc.’s revenue jumped 172.68% since last year same period to $0.53Mn in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 52800% jump in its revenue since last 3-months.

Cg Oncology Inc.’s net profit fell -95.36% since last year same period to $-16.93Mn in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated -5.06% fall in its net profits since last 3-months.

Cg Oncology Inc.’s net profit margin jumped 28.36% since last year same period to -3200.76% in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 99.8% jump in its net profit margins since last 3-months.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a 56.72% jump from last quarter’s estimates.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current year stand at -0.29.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cg Oncology Inc.’s return on assets (ROA) stands at 0.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cg Oncology Inc.’s return on equity (ROE) stands at 0.